Want to see SE:CRED.A full AI Analyst Report?
Top Page
Creades AB
(CRED.A)
Select Model
Select Model
Rating:72Outperform
Price Target:
kr97.00
▲(7.48% Upside)
Action:Reiterated
Date:10/15/26
The score is driven primarily by financial resilience (notably the very strong, low-debt balance sheet) and an attractive valuation (very low P/E). These positives are tempered by inconsistent earnings quality/volatility and a mixed technical picture with negative MACD and the stock trading below shorter-term moving averages.
Positive Factors
Conservative Balance Sheet
Extremely low debt relative to equity across all periods gives Creades substantial financial flexibility and downside protection. This supports continued portfolio ownership and capital allocation through weaker markets, while reducing the risk that interest obligations constrain returns.
Negative Factors
Earnings Volatility
Although profitability was strong in several recent annual periods, the large 2022 loss demonstrates that earnings can swing sharply across the cycle. Such variability makes reported profits less predictable and can reduce confidence in near-term earnings power even with a conservative balance sheet.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Extremely low debt relative to equity across all periods gives Creades substantial financial flexibility and downside protection. This supports continued portfolio ownership and capital allocation through weaker markets, while reducing the risk that interest obligations constrain returns.
Read all positive factors
Creades AB (CRED.A) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr11.38B
Dividend Yield1.91%
Average Volume (3M)115.75K
Price to Earnings (P/E)5.8
Beta (1Y)1.10
Revenue Growth6.97%
EPS Growth50.85%
CountrySE
Employees7
SectorGeneral
Sector StrengthN/A
IndustryAsset Management
Share Statistics
EPS (TTM)14.43
Shares Outstanding93,103,640
10 Day Avg. Volume110,586
30 Day Avg. Volume115,748
Financial Highlights & Ratios
PEG Ratio9.26
Price to Book (P/B)0.91
Price to Sales (P/S)7.81
P/FCF Ratio79.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Creades AB Business Overview & Revenue Model
Company Description
Established in 2011 and headquartered in Stockholm, Sweden, Creades AB operates as an investment entity focused on both private equity and venture capital. The firm's mandate is broad, covering the entire lifecycle of companies from nascent seed a...
How the Company Makes Money
Creades makes money primarily from the financial performance of its investment portfolio. Its key earnings drivers are: (1) dividends and other distributions received from portfolio companies; (2) realized capital gains when it sells all or part o...
Creades AB Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
88
Very Positive
Cash Flow
67
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -187.00M | 1.30B | 1.28B | 538.00M | -4.19B | 4.47B |
| Gross Profit | -188.00M | 1.27B | 1.27B | 538.00M | -4.19B | 4.47B |
| EBITDA | 1.96B | 1.22B | 1.20B | 560.00M | -3.96B | 4.22B |
| Net Income | 1.96B | 1.21B | 1.20B | 558.00M | -3.95B | 4.19B |
Balance Sheet | ||||||
| Total Assets | 12.90B | 11.25B | 10.31B | 9.32B | 9.05B | 13.52B |
| Cash, Cash Equivalents and Short-Term Investments | 91.00M | 287.00M | 717.00M | 299.00M | 613.00M | 467.00M |
| Total Debt | 7.00M | 8.00M | 10.00M | 2.00M | 3.00M | 6.00M |
| Total Liabilities | 210.00M | 95.00M | 153.00M | 147.00M | 245.00M | 575.00M |
| Stockholders Equity | 12.69B | 11.15B | 10.16B | 9.18B | 8.81B | 12.95B |
Cash Flow | ||||||
| Free Cash Flow | 204.00M | 128.00M | 190.00M | 205.00M | 25.00M | 89.00M |
| Operating Cash Flow | 205.00M | 128.00M | 190.00M | 205.00M | 25.00M | 89.00M |
| Investing Cash Flow | -163.00M | -341.00M | 438.00M | -329.00M | 311.00M | -1.07B |
| Financing Cash Flow | -216.00M | -217.00M | -210.00M | -190.00M | -190.00M | 805.00M |
Creades AB Technical Analysis
Negative
90.25
Price Trends
87.85
Negative
85.23
Negative
77.74
Positive
Market Momentum
-1.29
Positive
42.11
Neutral
24.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CRED.A, the sentiment is Negative. The current price of 90.25 is above the 20-day moving average (MA) of 84.95, above the 50-day MA of 87.85, and above the 200-day MA of 77.74, indicating a neutral trend. The MACD of -1.29 indicates Positive momentum. The RSI at 42.11 is Neutral, neither overbought nor oversold. The STOCH value of 24.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:CRED.A.
Creades AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | kr6.66B | 5.29 | ― | 5.05% | -8.09% | 220.60% | |
72 Outperform | kr11.38B | 5.81 | 16.53% | 1.91% | 6.97% | 50.85% | |
61 Neutral | kr22.66B | 4.51 | 24.04% | 0.90% | -3.49% | ― | |
59 Neutral | kr18.80B | 16.72 | 5.34% | 0.99% | 2.43% | 6.84% | |
58 Neutral | kr6.53B | 15.55 | 7.28% | 2.19% | 78.30% | 62.60% | |
57 Neutral | kr13.05B | -55.69 | -1.68% | 3.49% | -23.16% | -128.59% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
SE:CRED.A
Creades AB
83.85
8.17
10.80%
SE:RATO.B
Ratos AB
40.10
2.70
7.22%
SE:STOR.B
Storskogen Group AB Class B
11.15
1.26
12.74%
SE:BURE
Bure Equity AB
305.40
25.48
9.10%
SE:SVOL.B
Svolder AB Class B
61.75
6.97
12.72%
SE:ORES
Investment AB Oresund
146.60
34.86
31.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.